List of redirects

Showing below up to 50 results in range #981 to #1,030.

981. ASH → Hypertrophic cardiomyopathy
982. ASIS → Angina And Silent Ischemia Study
983. ASL (gene) → Argininosuccinate lyase
984. ASMA → Anti-SM antibody
985. ASO → Antistreptococcal antibodies
986. ASO titer → Antistreptolysin O titer
987. ASPAC → Asian-Pacific Collaboration On Chd Risk Factor Intervention
988. ASPA (gene) → Aspartoacylase
989. ASPECT-2 → Aspirin And Coumadin After Acute Coronary Syndromes (The Aspect-2) Study: A Randomised Controlled Trial.
990. ASPEN → ASPEN Trial
991. ASPEN trial → ASPEN Trial
992. ASPIRE → Arixtra Study In Percutaneous Coronary Intervention: A Randomized Evaluation
993. ASPM → ASPM (Genetics)
994. ASPSCR1 gene → ASPSCR1
995. ASRM → American Society of Reproductive Medicine
996. ASSENT-1 → Assessment Of The Safety Of A New Thrombolytic: Tnk-Tpa
997. ASSENT-2 → Assessment Of The Safety And Efficacy Of A New Thrombolytic: Tnk-Tpa-2
998. ASSENT-4 PCI → Assessment Of The Safety And Efficacy Of A New Treatment Strategy For Acute Myocardial Infarction
999. ASSENT 3 → The Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen (Assent)-3 Investigators. Efficacy And Safety Of Tenecteplase In Combination With Enoxaparin, Abciximab, Or Unfractionated Heparin: The Assent-3 Randomized Trial In Acute Mi
1000. ASSENT 3 PLUS → Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen-3
1001. ASSERT → Aortic Stentless Versus Stented Valve Assessed By Echocardiography Randomized Trial
1002. ASSET → Anglo-Scandinavian Study Of Early Thrombolysis
1003. ASSIST → Assessment Of Implementation Strategies
1004. ASSURE → Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit Of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter Defibrillator Implantations
1005. ASS (gene) → Argininosuccinate synthetase
1006. AST → Aspartate transaminase
1007. ASTAMI → Astami
1008. ASTEROID → A Study To Evaluate The Effect Of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden
1009. ASTEROID trial → ASTEROID Trial
1010. ASTIS → Autologous Stem Cell Transplantation International Scleroderma Trial
1011. ASTM → ASTM International
1012. ASTRAL → Angioplasty And Stenting For Renal Artery Lesions
1013. ASTRID → Atrial Sensing Trial To Prevent Inappropriate Detections
1014. ASTRONAUT → Acid Suppression Trial: Ranitidine Zantac Versus Omeprazole
1015. AS transthyretin amyloidosis → Cardiac amyloidosis
1016. AT → Ataxia telangiectasia
1017. AT-10 Resin → AT-10 resin
1018. AT/RT → Atypical teratoid rhabdoid tumor
1019. AT3 → Antithrombin III
1020. ATAC → Arimidex (Anastrozole), Tamoxifen And Combination Therapy
1021. ATBAT → Anticoagulant Therapy With Bivalirudin To Assist In Pci 1St Inning Trial (Pci In Hit/Hitts)
1022. ATBC → Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study
1023. ATC → Anaplastic thyroid cancer
1024. ATC code → Anatomical Therapeutic Chemical Classification System
1025. ATC codes → Anatomical Therapeutic Chemical Classification System
1026. ATF1 gene → ATF1
1027. ATF2 → Activating transcription factor 2
1028. ATG → Anti-thymocyte globulin
1029. ATG or AUG → Start codon
1030. ATHENA → Effect Of Dronedarone On Cardiovascular Outcomes In High-Risk Patients With Atrial Fibrillation Or Atrial Flutter